Clinical Trial Update: Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating skin toxicity in metastatic colorectal cancer patients treated with anti-EGFR therapy plus chemotherapy (DERMIA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer | Conditions: Skin Toxicity | Phase 2 | Status: COMPLETED